Search Results 101-110 of 13728 for monoclonal antibody
Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... antibodies and the factors that may ...
Brentuximab vedotin is a combining monoclonal antibody with an anticancer drug that binds to a protein on the surface of lymphoma cells called cluster of ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
Medicines known as monoclonal antibodies may prevent beta-amyloid from clumping into plaques. ... The monoclonal antibody solanezumab did not show benefits for ...
Interrupting the Progression of COVID-19 by Anti-Spike Monoclonal Antibodies: Outcomes in Two Eras ... Eligibility for anti-spike monoclonal antibody therapy ...
Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as rituximab, may block ...
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may ... Rituximab is a monoclonal antibody. It binds to a protein called CD20, which ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.